Is Melanotan II safe?
Emerging ResearchSide effects, risks, and safety considerations based on available research.
Research status
Melanotan II has some clinical data but research is still developing. Safety data exists but may come from small studies, short-term trials, or specific populations that may not reflect your situation.
Known concerns & side effects
- ⚠not approved by any regulatory agency worldwide
- ⚠non-selective receptor activation causes nausea, facial flushing, and fatigue
- ⚠may darken existing moles and could theoretically promote melanoma in predisposed individuals
- ⚠unregulated supply — contamination and mislabeling are common
- ⚠long-term safety data in humans is essentially absent
- ⚠associated with cases of rhabdomyolysis and renal injury in case reports
Use caution with
Relevant safety research
Subcutaneous Melanotan II and skin pigmentation in Caucasian subjects
Finding: Melanotan II induced significant skin darkening without UV exposure after 5 days of subcutaneous injection. Tanning was most pronounced in facial and arm skin.
Limitation: Very small sample, short duration, no long-term safety follow-up.
See all 2 studies on the full Melanotan II profile.
Frequently asked questions
Is Melanotan II safe?
There is no regulatory agency that has approved Melanotan II as safe for human use. Case reports describe serious adverse events including mole changes, cardiovascular events, and kidney injury. The unregulated supply chain adds further risk from contamination. Dermatologists and regulatory bodies broadly advise against its use.
Does Melanotan II protect against sunburn?
While increased melanin provides some UV protection, it is not a substitute for sunscreen. The tanning produced by Melanotan II is primarily cosmetic. Users can and do still burn, and any UV exposure while using the peptide could accelerate pigmentary changes in moles.
How is Melanotan II different from Melanotan I?
Melanotan I (afamelanotide) is more selective for MC1R and was FDA-approved as Scenesse for erythropoietic protoporphyria (EPP). Melanotan II is non-selective, activating multiple melanocortin receptors, which gives it the sexual and appetite effects but also more side effects. Melanotan I is considered significantly safer.
Full Melanotan II Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2025-04-09
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.